Overview

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.
Phase:
Phase 4
Details
Lead Sponsor:
Kowa Research Institute, Inc.
Collaborators:
Eli Lilly and Company
Kowa Pharmaceuticals America, Inc.
Treatments:
Pitavastatin
Pravastatin